1. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? 
Marie Méan, MD, Andreas Limacher, PhD, Odile Stalder, MSc, Anne Angelillo-Scherrer, MD, Lorenzo Alberio, MD, Pierre Fontana, MD, PhD, Hans-Jürg Beer, MD, Nicolas Rodondi, MD, MAS, Bernhard Lämmle, MD, Drahomir Aujesky, MD, MSc 
The American Journal of Medicine 
Volume 130, Issue 10, Pages 1220.e e22 (October 2017)
DOI: /j.amjmed
Copyright © 2017 Elsevier Inc. Terms and Conditions

2. Figure
Cumulative incidence of recurrent venous thromboembolism. The cumulative 36-month incidence of venous thromboembolism was 12.9% (95% confidence interval [CI], 5.1%-30.8%) in patients with a Factor V Leiden, 18.5% (95% CI, 4.9%-56.5%) in patients with a prothrombin G20210A, and 16.7% (95% CI, 12.5%-22.1%) in patients without mutation (P = .91 by the log-rank test).
The American Journal of Medicine  , 1220.e e22DOI: ( /j.amjmed )
Copyright © 2017 Elsevier Inc. Terms and Conditions